Navigation Links
Dehaier Medical Announces 2012 Second Quarter and Six Month Financial Results

BEIJING, Aug. 13, 2012 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (Nasdaq: DHRM) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products, today announced its financial results for its second quarter and six months ended June 30, 2012.

(Logo: )

Comments from ManagementMr. Ping Chen, Chief Executive Officer of Dehaier Medical, stated, "Throughout the first half of 2012, we continued to focus on diversifying our revenues.  While we have continued to build on our medical device sales and distribution foundation, we have also devoted sales resources to growing our proprietary respiratory and oxygen homecare products, explored international expansion possibilities and put more energy into developing and researching homecare products and protecting our intellectual property. Throughout this process we have continued to report strong operating profits.  We improved our gross and operating margins and continue to leverage a strong balance sheet with minimal long-term debt.  We believe that our business will continue to grow at a healthy rate in the long term as we strengthen our medical device distribution network; increase the market recognition and demand for our proprietary products; research, develop and begin to sell new products; and ramp up our international expansion."

Operating Highlights

  • In April 2012, Dehaier renewed its strategic cooperation agreement with Timesco of London Ltd ("Timesco"). The agreement appointed Dehaier as the exclusive distributor for Timesco's CXL and Eclipse series laryngoscope products in mainland China for three years.
  • In May 2012, the Company extended its exclusive distribution authorization with INTERMEDICAL ("IMD"), to distribute IMD's RADIUS C-arm X-ray machines in mainland China. The extended term runs through 2014.
  • In June 2012, Dehaier entered a three-year strategic mutual cooperation agreement with HEYER Medical AG ("Heyer"). According to this agreement, Dehaier will continue to be one of the key Chinese distributors for Heyer's anesthesia machines and the exclusive distributor of its nebulizers in China. 
  • Also in June 2012, the Company co-developed a "High-Efficiency Oxygen Inhaler" with Dr. Ding Jianzhang of Beijing Haidian Hospital. This inhaler is expected to begin selling in mainland China in the third quarter of 2012. The portable device is designed for use in homecare oxygen therapy, emergency treatment, disaster relief activities and high-altitude settings.
  • Between April and June 2012, the company obtained software copyrights from China's National Copyright Administration for four of its proprietary technologies, including (1) Analysis and Monitoring Software of Adsorption Tower Oxygen Generation Process, (2) Dehaier Homecare CPAP Controlling Software, (3) Ventilator of CPAP Controlling Software and (4) Air Compressor Controlling Software. These copyrights have been approved for 50 years from the grant date.
  • In July 2012, Dehaier received approval from China's State Food and Drug Administration ("SFDA") for its proprietary homecare medical CPAP device, the DHR-CPAP-C5.
  • Second Quarter 2012 Financial Highlights

  • Total revenues were $7.0 million for the three months ended June 30, 2012, compared to $7.7 million in the prior-year quarter.  The decrease was largely a result of the aforementioned change in operating strategy to focus on Dehaier's own homecare products and larger government procurement projects.
  • The Company's gross profit for the quarter ended June 30, 2012 was $2.7 million, or 39.2% of revenue, compared to $2.8 million, or 36.8% of revenue, in the prior-year period.  Gross margin improved largely as a result of improved operating efficiencies and inventory management.
  • Dehaier's income from operations improved slightly, or 0.1%, to $1,928,212 in the 2012 second quarter from $1,925,024 in the prior-year period, largely due to lower selling expenses for the period. The Company expects its selling expenses to grow as it invests in strengthening its distribution network, growing relationships with customers, developing the homecare device market (in particular its oxygen therapy service initiative) and driving top-line growth in these areas.
  • The Company reported net income attributable to the Company of $1.7 million, or $0.36 per diluted share in the 2012 second quarter, compared to $1.7 million, or $0.39 per diluted share in the prior year.
  • Fiscal 2012 Six Month Financial Highlights

  • Total revenues decreased by 3% to $10.3 million for the six months ended June 30, 2012, from $10.7 million in the prior-year period.
  • The Company's gross profit for the six months ended June 30, 2012 was $4.0 million, or 39% of revenue, compared to $3.8 million, or 36% of revenue, in the prior-year period. 
  • Dehaier's income from operations improved 7% to $2.4 million for the six months ended June 30, 2012, from $2.2 million in the prior-year period.
  • The Company reported net income attributable to the Company of $1.8 million, or $0.39 per diluted share in the six months ended June 30, 2012, compared to $1.9 million, or $0.43 per diluted share in the prior year.
  • Balance Sheet Highlights(in millions)6/30/201212/31/2011Cash and Cash Equivalents




    3.7Working Capital25.927.0Total Long-term Debt00Stockholders' Equity31.930.2

  • As a result of the total cash activities, net cash decreased from $3.7 million at December 31, 2011 to $1.1 million at June 30, 2012. This is mainly because we invested in obtaining copyright protection for our software, for our future development.
  • The Company believes that its currently available working capital of $25.9 million, including cash of $1.1 million, should be adequate to meet its anticipated cash needs and sustain its current operations for at least 12 months.
  • About Dehaier Medical Systems Ltd.Dehaier is an emerging leader in the development, assembly, marketing and sale of medical products, including respiratory and oxygen homecare medical products. The Company develops and assembles its own branded medical devices and homecare medical products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD (Italy), HEYER (Germany), Timesco (UK) and eVent Medical (US). Dehaier's technology is based on six patents and five software copyrights; additionally Dehaier has two pending software copyrights and proprietary technology. More information may be found at

    Forward-looking StatementsThis news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events, government approvals or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, future developments in payment for and demand for medical equipment and services, implementation of and performance under the joint venture agreement by all parties, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

    Contact UsDehaier Medical Systems Limited
    Surie Liu
    +86 10-5166-0080

    Dehaier Medical Systems Limited
    Tina He
    +86 10-5166-0080


    (Tables to Follow)

    (UNAUDITED)For the six months ended
    June 30,For the three months ended
    June 30,2012201120122011US$US$US$US$Revenue 10,299,05910,665,4906,983,1287,712,784Costs of revenue (6,317,316)(6,826,494)(4,242,660)(4,871,247)Gross profit 3,981,7433,838,9962,740,4682,841,537Service income

    132,915156,42892,51871,595Service expenses

    (37,272)(61,372)(19,812)(20,675)General and administrative expense

    (1,031,502)(1,016,167)(540,789)(512,641)Selling expense

    (662,852)(694,493)(344,173)(454,792)Operating Income 2,383,0322,223,3921,928,2121,925,024Financial expenses (including interest expense of $64,904, $26,993, $37,741 and $10,816 for the six and three months ended June 30, 2012 and 2011, respectively)

    (65,969)(27,472)(38,320)(11,859)Non-operating Income

    395-395-Change in fair value of warrants liability

    (92,067)149,867107,441140,341Income before provision for income taxes and non-controlling interest  2,225,3912,345,7871,997,7282,053,506Provision for income tax

    (416,468)(396,642)(319,420)(314,105)Net income 1,808,9231,949,1451,678,3081,739,401Non-Controlling interest in (income) loss

    7,478(5,654)12,072(1,324)Net income attributable to Dehaier Medical Systems Limited 1,816,4011,943,4911,690,3801,738,077Net Income1,808,9231,949,1451,678,3081,739,401Other comprehensive incomeForeign currency translation adjustments

    (226,067)511,375(268,862)324,095Comprehensive Income1,582,8562,460,5201,409,4462,063,496Comprehensive income attributable to the non-controlling interest

    21,019(28,591)13,253(17,685)Comprehensive income attributable to Dehaier Medical Systems Limited1,603,8752,431,9291,422,6992,045,811Earnings per share-Basic


    0.390.430.360.39Weighted average number of common shares used in computation-Basic


    4,714,0774,506,3544,717,6394,510,000 DEHAIER MEDICAL SYSTEMS LIMITED AND AFFILIATE
     (UNAUDITED)June 30, December 31,20122011US$US$ASSETSCURRENT ASSETS:Cash and cash equivalents

    1,107,9423,694,486Accounts receivable
    -less allowance for doubtful accounts of $880,587 and $859,509

    12,414,58812,159,842Other receivables

    4,192,7592,522,136Prepayment and other current assets

    7,288,5156,714,001Inventories, net

    4,799,3025,532,311Tax receivable

    503,853888,452Deferred tax asset

    117,110118,030Total Current Assets 30,424,06931,629,258Property and equipment, net

    3,063,3663,348,533Intangible assets, net

    2,393,781-Total Assets 35,881,21634,977,791LIABILITIES AND EQUITY CURRENT LIABILITIES:Short-term borrowings

    2,360,2951,585,890Accounts payable 

    39,04032,925Advances from customers

    237,653303,000Accrued expenses and other current liabilities

    319,836349,158Taxes payable

    425,0892,042,048Warranty obligation

    332,072334,680Total Current Liabilities 3,713,9854,647,701OTHER LIABILITIESWarrants liability

    286,04196,469Total Liabilities4,000,0264,744,170Commitments and ContingencyEquity Common shares, $0.002731 par value, 18,307,038 shares authorized, 4,570,000 and 4,560,000 shares issued and outstanding at June 30, 2012 and December 31, 2011, respectively

    12,48112,454Additional paid in capital

    13,359,60213,281,374Retained earnings

    14,757,97212,941,572Accumulated other comprehensive income

    2,359,4212,585,488Total Dehaier Medical Systems Limited shareholders' equity 30,489,47628,820,888Non-controlling interest

    1,391,7141,412,733Total equity 31,881,19030,233,621Total liabilities and equity 35,881,21634,977,791 DEHAIER MEDICAL SYSTEMS LIMITED AND AFFILIATE
    (UNAUDITED)For the six months ended June 30,20122011US$US$Cash flows from operating activitiesNet income1,808,9231,949,145Adjustments to reconcile net income to net cash used in operating activitiesStock-based compensation expense124,07759,300Depreciation and amortization246,448219,976Change in fair value of warrants liability92,067(149,867)Recovery of doubtful accounts27,942-Changes in assets and liabilities: Increase in accounts receivable(282,688)(3,451,269)Increase in prepayments and other current assets(522,831)(4,240,759)Decrease (Increase) in other receivables(1,670,623)2,810Decrease (Increase) in inventories733,00996,299Decrease in tax receivable384,599(911,942)Increase (Decrease) in accounts payable6,1151,153,882Decrease in advances from customers(65,347)(116,220)Increase in accrued expenses and other current liabilities(31,931)9,502Increase in tax payable(1,616,959)2,022,812Net cash used in operating activities(767,199)(3,356,331)Cash flows from investing activitiesAcquisition of machinery and software copyrights(2,405,707)(62,302)Advances to related parties-(2,358)Net cash used in investing activities(2,405,707)(64,660)Cash flows from financing activitiesProceeds from bank loan2,373,1451,542,680Repayment of bank loan(1,580,436)(1,533,604)Net cash provided by financing activities792,7099,076Effect of exchange rate fluctuations on cash and cash equivalents (206,347)496,552Net decrease in cash and cash equivalents(2,586,544)(2,915,363)Cash and cash equivalents at beginning of period3,694,4865,923,386Cash and cash equivalents at end of period1,107,9423,008,023Supplemental cash flow informationIncome tax paid779,67813,260Interest paid64,90426,993

    SOURCE Dehaier Medical Systems Ltd.
    Copyright©2012 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Dehaier Medical to Report 2012 Second Quarter and First Half Financial Results on August 13, 2012
    2. Dehaier Medical Receives Software Copyrights for Four Proprietary Technologies
    3. Dehaier Medical Announces Strategic Mutual Cooperation Agreement with HEYER Medical AG
    4. Dehaier Medical to Present at the CFA 2012 Cross-Continental Summit on Investment in Shanghai
    5. Dehaier Medical Announces 2012 First Quarter Financial Results
    6. Dehaier Medical to Report First Quarter 2012 Financial Results on May 9th, 2012
    7. Erich R. Reinhardt Appointed to Board of Directors of Varian Medical Systems
    8. Varian Medical Systems Board of Directors Authorizes Repurchase of Additional 8 Million Shares of Stock through Calendar Year 2013
    9. Varian Medical Systems CEO Timothy E. Guertin Announces Plans to Retire; Board of Directors Names Dow R. Wilson as Successor
    10. Tactical Medical Packs Announces New Disaster Medical Packs Equipping First Responders for Mass Casualty Incidents
    11. IPS Appoints Dr. Avrom Gart, M.D. as Medical Director
    Post Your Comments:
    (Date:11/26/2015)... 2015 ... the  "2016 Future Horizons and Growth ... Marker Testing Market: Supplier Shares, Competitive ... offering.  --> ) ... "2016 Future Horizons and Growth Strategies ...
    (Date:11/25/2015)... , Nov. 25, 2015  The American ... and Gynecologists (ACOG), and the March of Dimes ... Protecting Our Infants Act of 2015 ... number of newborns born exposed to drugs, such ... the bill,s introduction, all three organizations have worked ...
    (Date:11/25/2015)... Nov. 25, 2015  ARKRAY USA ... to provide evidence demonstrating the accuracy of its blood ... on Insulin Resistance, Diabetes and Cardiovascular Disease in ... the Company,s GLUCOCARD ® 01 meter and the ... requirements. The ability to accurately measure glucose levels in ...
    Breaking Medicine Technology:
    (Date:11/27/2015)... ... November 27, 2015 , ... A simply groundbreaking television series, "Voices ... show that delves into an array of issues that are presently affecting Americans. Dedicated ... open dialogue, this show is changing the subjects consumers focus on, one episode at ...
    (Date:11/27/2015)... , ... November 27, 2015 , ... Dr. Thomas ... Associates, Inc. and Dr. Tucker Bierbaum with Emergency Medicine at St., Joseph ... that both STEMI and Sepsis conditions present in similar ways and require time-critical intervention ...
    (Date:11/26/2015)... ... November 26, 2015 , ... ... system for diagnostic imaging in the Waterloo region. Using the Ocean Platform, family ... tests directly from their electronic medical record (EMR) without the need for redundant ...
    (Date:11/26/2015)... ... November 26, 2015 , ... WorldCare International, Inc., the ... 61st annual Employee Benefits Conference. The Employee Benefits Conference was hosted by the ... Wednesday, November 11th, 2015. The conference was held at the Hawaii Convention Center ...
    (Date:11/25/2015)... ... November 25, 2015 , ... As part of ... Empowerment ™ attracts volunteers together who want to combine talents and resources to ... stakeholders in the process. The non-profit launched its first major fundraiser on November ...
    Breaking Medicine News(10 mins):